Stay updated on Eli Lilly and Company Press Releases

Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Eli Lilly and Company Press Releases page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    New entries highlight positive retatrutide obesity trial results (TRIUMPH-2 and TRIUMPH-3) and the date of Lilly’s second‑quarter 2026 financial results conference call, expanding the page’s coverage of product news and investor communications. At the same time, older items about a JAK2 inhibitor data release and a Zepbound sleep apnea campaign were removed, narrowing the page’s focus to more current announcements.
    Difference
    8%
    Check dated 2026-07-24T22:09:15.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Lilly announces the acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and expand its neuroscience portfolio. The page also removes the EBGLYSS FDA-approval release, updating the press releases feed to reflect current news.
    Difference
    4%
    Check dated 2026-07-17T19:03:44.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    New items add analyses across Kisunla trials and new P-tau217 data, and announce Lilly’s Alzheimer’s research at AAIC 2026. Simultaneously, two older Foundayo trial-result statements were removed, altering how those trial outcomes are presented.
    Difference
    2%
    Check dated 2026-07-10T16:17:38.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    New press releases announce CHMP's positive opinion for Jaypirca in EU CLL and a Europe-wide Memory Radio Station campaign. Older weight-management data involving Foundayo and retatrutide have been removed from the page.
    Difference
    8%
    Check dated 2026-07-03T03:24:52.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    New items were added to the press release list, including Medicare pathway updates for Foundayo and Zepbound, the Centessa acquisition, the Q3 dividend, and the healthcare provider hub. Older press release entries were removed to reflect current archives on the page.
    Difference
    10%
    Check dated 2026-06-25T22:14:37.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Added new press releases featuring BRUIN CLL-322 data for Jaypirca in CLL/SLL and the first-in-class type II JAK2 inhibitor AJX-101 data with a 2026 EHA presentation (dated 06/13–06/14/2026). Removed older announcements about Foundayo and Zepbound coverage milestones and Lilly's conference participation.
    Difference
    7%
    Check dated 2026-06-18T19:22:59.000Z thumbnail image

Stay in the know with updates to Eli Lilly and Company Press Releases

Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.